This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?
Last week I received an excellent article from Variant Perception on "Market Tops", and have permission to excerpt some of it. Here is a link to the summary page of Understanding Market Tops. Framework for Understanding Tops In the following table, we summarize the signs of market bottoms and tops. Insiders, however, are smart.
She was on the legal compliance team at a fast-growing biotechnology company. Her role was to work with marketing to ensure that promotional campaigns and materials were in line with government guidelines. Karen had always been invited to key marketing meetings, but she noticed that more and more meetings were happening without her.
McKinsey’s Bay Area offices serve major technology and financial firms, as well as leading healthcare and retail companies needing strategy and innovation help. Here’s why: the firm’s leadership is always looking for new strategy and new, creative ways to bring value to clients. Deloitte Consulting , 101 Market St.,
In 2013, the New York office was established, providing a home base in one the most important finance and legal markets in the world. In healthcare, the firm focuses on the enormous and fast-growing sectors of pharmaceuticals, medical devices, and biotechnology. THE BRATTLE GROUP ORGANIZATION. Office Locations. Cambridge, MA.
But should leaders even bother spending time trying to develop employees and plan for the future, given the turbulence in the labor market and uncertainty in the world? Today this stems from rapid advances in the fields of robotics, artificial intelligence, biotechnology, advanced materials, and genomics.
We find two primary ends of a spectrum with respect to how companies make decisions – each with its advantages and drawbacks depending upon the corporate strategy. Examples of common fact-based decision making cultures include biotechnology, finance, and medical device companies. A Fact-Based Decision Making Culture.
After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. Gillette dominated the men’s shaving market with its Mach series of razors. ” — an edge strategy approach to M&A can mitigate the risks of an inherently risky business.
The Fourth Industrial Revolution includes developments artificial intelligence, robotics, nanotechnology, 3-D printing, genetics, and biotechnology. Sitka Pacific is an asset management firm whose goal is strong performance and low volatility, regardless of market direction. million jobs will vanish in the world's 15 leading countries.
Scientists really did create those Frankentomatoes, but they were never put on the market. The tomato that did make it to market was called the Flavr Savr, engineered for longer shelf life. Yet it was placed on the market without required labels, warnings, or post-marketing surveillance.
However, I fear that Mexico continuing its existing trade-based economic strategy will not necessarily produce different results in the long term — as it wouldn’t for any other developing country. There’s another way, a race-to-the-top strategy. A shift in relations is required between developed and emerging markets.
As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. A weakened FDA would not only endanger patient safety but also introduce market uncertainty that biotech companies can ill afford.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content